30
Participants
Start Date
November 6, 2020
Primary Completion Date
May 14, 2021
Study Completion Date
September 1, 2021
Ex vivo expanded Wharton's Jelly Mesenchymal Stem Cells
"Ex vivo expanded Wharton's Jelly derived mesenchymal stem cells will be infused at day 0, day 3 and day 5 (+/- 1 day), in patients with moderate to severe ARDS with a mechanical ventilation.~day 0: 1.10\^6 MSC/kg day 3: 0.5. 10\^6 MSC/kg day 5: 0.5 . 10\^6 MSC/kg"
Placebo
Only the vehicle solution, without MSCs, containing albumin 4% , NaCl 0,9% and ACD will be injected to patients at day 0, 3 and 5 (+/-1 day).
Nancy University Hospital, Vandœuvre-lès-Nancy
Central Hospital, Nancy, France
OTHER